All Stories

  1. Waist circumference as a mediator in the association between sarcopenia and cognitive function
  2. A Five-Year Study on Treatment Changes in Hypoglycemia-Associated Medications: Towards Personalized Diabetes Management
  3. Long‐Term Adherence and Drug Utilisation Patterns Among New Users of Anti‐Hyperlipidemic Monotherapy: Development of a Risk Prediction Model
  4. Analysis of trends and driving factors in burden of Alzheimer's disease and other dementias from 1990 to 2021 and projections for 2050: A comprehensive perspective based on GBD 2021
  5. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
  6. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  7. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  8. Real-world effectiveness of antibiotics in addition to oral corticosteroids for managing asthma exacerbations in adults
  9. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  10. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
  11. Burden of neurological disorders in China and its provinces, 1990–2021: Findings from the global burden of disease study 2021
  12. Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  13. LASSO logistic regression and cluster analysis in predicting adherence and drug patterns among new users of monotherapy for antihypertensive drugs
  14. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  15. Epidemiological and sociodemographic transitions in the global burden and risk factors for Alzheimer's disease and other dementias: a secondary analysis of GBD 2021
  16. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  17. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
  18. Mapping the Global distribution, risk factors, and temporal trends of COPD incidence and mortality (1990–2021): ecological analysis
  19. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  20. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  21. Modelling Asthma Treatment Dynamics: Insights from the g-Formula
  22. Health dynamics in war-torn Yemen: insights from 32 years of epidemiological data (1990–2021)
  23. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
  24. A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease
  25. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
  26. Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019
  27. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
  28. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  29. The Global Burden of Diarrheal Diseases: Causes, Risks, and Trends (1990–2021)
  30. Population-Level Distribution, Risk Factors, and Burden of Mortality and Disability-Adjusted Life Years Attributable to Major Noncommunicable Diseases in Western Europe (1990-2021): Ecological Analysis
  31. Psychometric Properties and Measurement Equivalence of the Workplace Incivility Scale Across Cultures: Insights from Daily Diary Study
  32. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  33. Comparative Effectiveness of Anti-Hyperlipidemic Drugs Monotherapy in Primary Prevention of Cardiovascular Disease
  34. Comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events—a real-world longitudinal inception cohort study
  35. Epidemiology and demographic patterns of cardiovascular diseases and neoplasms deaths in Western Europe: a 1990–2019 analysis
  36. Epidemiological trends and age-period-cohort effects on cardiovascular diseases burden attributable to ambient air pollution across BRICS
  37. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis
  38. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  39. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  40. Burden of disease scenarios for 204 countries
  41. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  42. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  43. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  44. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  45. Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS‐plus, 1990–2019: A comparable study of key nations with emerging economies
  46. Does supervisor mistreatment lead to subordinates’ incivility at work? Evidence from a cross-cultural daily diary
  47. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
  48. The adverse effect of gestational diabetes mellitus and hypertensive disorders of pregnancy on maternal–perinatal outcomes among singleton and twin pregnancies: a retrospective cohort study (2011–2019)
  49. Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: results from the Global Burden of Disease Study 2021
  50. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories
  51. Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus
  52. Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transitions across BRICS-Plus Countries
  53. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  54. Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transition across BRICS-Plus
  55. Risk assessment of dietary factors in global pattern of ischemic heart disease mortality and disability-adjusted life years over 30 years
  56. Epidemiological trend and age-period-cohort effects on cardiovascular disease mortality and disability-adjusted life years attributable to dietary risks and high body mass index at the regional and country level across China and Pakistan
  57. A moderated mediation model between perceived incivility and instigated incivility on workplace: A cross-cultural daily diary study.
  58. Breast cancer epidemiology and sociodemographic differences in BRICS-plus countries from 1990 to 2019: An age period cohort analysis
  59. A Mediation Moderation Model between Self-Evaluative Emotions and Relapse Rate among Polysubstance Users: A Comparative Cross-Sectional Study
  60. Evaluation of Lee–Carter model to breast cancer mortality prediction in China and Pakistan
  61. More recent insights into the breast cancer burden across BRICS-Plus: Health consequences in key nations with emerging economies using the global burden of disease study 2019
  62. Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data
  63. The temporal trend of disease burden attributable to metabolic risk factors in China, 1990–2019: An analysis of the Global Burden of Disease study
  64. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  65. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  66. Mixed exposure to phenol, parabens, pesticides, and phthalates and insulin resistance in NHANES: A mixture approach
  67. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  68. Time trends in tuberculosis mortality across the BRICS: an age-period-cohort analysis for the GBD 2019
  69. Shame and guilt activations: Associations and sociodemographic differences among ploysubstance abusers
  70. Prediction of cardiovascular diseases mortality- and disability-adjusted life-years attributed to modifiable dietary risk factors from 1990 to 2030 among East Asian countries and the world
  71. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  72. Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study
  73. An efficient application of scrambled response approach to estimate the population mean of the sensitive variables
  74. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  75. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  76. Combined exposure to multiple metals on serum uric acid in NHANES under three statistical models
  77. Type-2 Diabetes Mellitus (T2DM): Spatial-temporal Patterns of Incidence, Mortality and Attributable Risk Factors from 1990 to 2019 among 21 World Regions
  78. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  79. The trend in delayed childbearing and its potential consequences on pregnancy outcomes: a single center 9-years retrospective cohort study in Hubei, China
  80. Correction to: Demographics of road injuries and micromobility injuries among China, India, Japan, and the United States population: evidence from an age-period-cohort analysis
  81. Association of Serum 25(OH)D, Cadmium, CRP With All-Cause, Cause-Specific Mortality: A Prospective Cohort Study
  82. Demographics of road injuries and micromobility injuries among China, India, Japan, and the United States population: evidence from an age-period-cohort analysis
  83. Lifestyle and Socioeconomic Transition and Health Consequences of Breast Cancer in the East Asia Region, From 1990 to 2019
  84. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  85. Changes in adverse pregnancy outcomes in women with advanced maternal age (AMA) after the enactment of China’s universal two-child policy
  86. Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries
  87. Age–Period–Cohort Analysis of Long Trend of Mortality for Stroke and Subtypes Attributed to High SBP in Chinese Adults
  88. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  89. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  90. Long-Term Changes of HIV/AIDS Incidence Rate in China and the U.S. Population From 1994 to 2019: A Join-Point and Age-Period-Cohort Analysis
  91. Lung Cancer Death Attributable to Long-Term Ambient Particulate Matter (PM2.5) Exposure in East Asian Countries During 1990–2019
  92. Global, regional, and national sex-specific burden and control of the HIV epidemic
  93. Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990–2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017
  94. Long-term trends of tuberculosis incidence and mortality in four central African countries
  95. Characterization and influencing factors of the pig movement network in Hunan Province, China
  96. Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis
  97. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  98. Correction to: Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990–2017 using hierarchical age-period-cohort analysis
  99. The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China
  100. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study
  101. Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990–2017 using hierarchical age-period-cohort analysis
  102. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  103. Trend dynamics of thyroid cancer incidence among China and the U.S. adult population from 1990 to 2017: a joinpoint and age-period-cohort analysis
  104. The Trend of HIV/AIDS Incidence and Risks Associated with Age, Period, and Birth Cohort in Four Central African Countries
  105. Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan
  106. DIAGNOSTIC ACCURACY OF DRUG SCREENING IMMUNOASSAYS IN DRUG FACILITATED CRIMES
  107. Corrigendum to: Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective, observational study
  108. Effect of preeclampsia and premature rupture of membrane on neonatal birth weight and length by gestational age: A retrospective study in China
  109. The Comparison of Epidemiological Characteristics Between Confirmed and Clinically Diagnosed Cases With COVID-19 in Wuhan, China
  110. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  111. A multi-country comparison of stochastic models of breast cancer mortality with P-splines smoothing approach
  112. Correction to: The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China
  113. The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China
  114. Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study
  115. Use of ATR-FTIR for detection ofSalmonella typhiinfection in human blood sera
  116. Trend Dynamics of Thyroid Cancer Incidence among China and the U.S. Adult Population from 1992-2017: A Join-point and Age-Period-Cohort
  117. The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017
  118. Correlation of MSH2 exonic deletions and protein downregulation with breast cancer biomarkers and outcome in Pakistani women/patients
  119. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2)
  120. Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China
  121. Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990–2017: A Joinpoint and Age–Period–Cohort Analysis
  122. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis
  123. Age-period-cohort analysis of kidney cancer deaths attributable to high body-mass index in China and U.S. adults
  124. Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models
  125. A Hierarchical Age–Period–Cohort Analysis of Breast Cancer Mortality and Disability Adjusted Life Years (1990–2015) Attributable to Modified Risk Factors among Chinese Women
  126. An Updated Trend Analysis Representing the Outbreak of Novel Coronavirus (2019-nCoV) in 16 Cities of Hubei Province, China Using Logistic S-Curve Model
  127. Ischemic Heart Disease Burden and Attributable  Risk Factors in 195 Countries and Territories, 1990-2017: Results from the Global Burden of Disease Study 2017
  128. Correlation of MLH1 polymorphisms, survival statistics, in silico assessment and gene downregulation with clinical outcomes among breast cancer cases
  129. FTIR spectroscopy of freeze-dried human sera as a novel approach for dengue diagnosis
  130. Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model
  131. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990–2017: A Joinpoint and Age–Period–Cohort Analysis
  132. An insight into clinical outcome of XPG polymorphisms in breast cancer